View Post

Cancer Screening Gaps Highlight Urgent Need to Address Health Inequities, According to NCCN Policy Summit

In In The News by Barbara Jacoby

National Comprehensive Cancer Network’s #NCCNPolicy Summit, featuring White House Moonshot Coordinator and representatives from CDC, NCI, and USPSTF, examines critical need for improvements in cancer prevention and early detection across the United States. Today, the National Comprehensive Cancer Network® (NCCN®) hosted a policy summit to examine practice changes and trends in legislative and regulatory efforts that affect patient access to …

View Post

Clarifying Expert Recommendations for Breast Cancer Screening

In In The News by Barbara Jacoby

From: nccn.org The National Comprehensive Cancer Network® (NCCN®) has published new NCCN Guidelines for Patients®: Breast Cancer Screening and Diagnosis to help people understand their personal risk for breast cancer, when they should begin screening, and how often to screen—in order to detect cancer earlier, for more treatment options and better outcomes. With this information, they are equipped to have more …

View Post

NCCN Now Recommends Breast Cancer Index for Predicting Benefit from Extended Endocrine Therapy

In Clinical Studies News by Barbara Jacoby

By: Audrey Sternberg From: cancernetwork.com The Breast Cancer Index assay is the only of its kind to be recommended in the National Comprehensive Cancer Network Guidelines for the treatment of breast cancer as being predictive of extended adjuvant endocrine therapy. Breast Cancer Index (BCI), a molecular gene expression–based test used for determining which patients with early-stage, hormone receptor (HR)–positive breast …

View Post

New Pediatric Cancer Guidelines Published by National Comprehensive Cancer Network Focus on Improving Long-Term Outcomes Worldwide

In In The News by Barbara Jacoby

New NCCN Guidelines for Pediatric Aggressive Mature B-Cell Lymphomas address best practices for treating children with common and curable forms of non-Hodgkin lymphoma Today, the National Comprehensive Cancer Network® (NCCN®) published new guidelines for treating children, adolescents and young adults with pediatric aggressive mature B-cell lymphomas, including Burkitt lymphoma and diffuse large B-cell lymphoma. NCCN published the first pediatric NCCN …

View Post

Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit

In In The News by Barbara Jacoby

From: www.nccn.org The National Comprehensive Cancer Network® (NCCN®) hosted a policy summit at the National Press Club in Washington, DC, today, addressing how to define, measure, and apply quality in cancer care. Speakers across the cancer care continuum shared perspectives on current quality measurement initiatives including the Oncology Care Model and the Merit-based Incentive Payment System (MIPS), and looked ahead …

View Post

New Patient Resource from NCCN Helps People with Bladder Cancer Make Informed Treatment Decisions

In In The News by Barbara Jacoby

New NCCN Guidelines for Patients: Bladder Cancer explains the lengthy surveillance process that follows active treatment for the sixth most-common cancer in the United States. The treatment landscape for bladder cancer has changed dramatically over the past few years. Despite being the sixth most common cancer in the United States, and fourth most common for men—impacting an estimated 81,000 Americans …

View Post

CureMD Oncology Integrates NCCN Templates

In In The News by Barbara Jacoby

From: prweb.com The National Comprehensive Cancer Network® (NCCN®) is collaborating with CureMD to integrate the NCCN Chemotherapy Order Templates (NCCN Templates®) into the CureMD Oncology EHR to allow for point-of-care access to treatment recommendations and order templates derived from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). The National Comprehensive Cancer Network® (NCCN®) is collaborating with CureMD to integrate …

View Post

NCCN: Updated Guidelines Reflect Advances, ‘Immunotherapy Era’ for Breast Cancer

In In The News by Barbara Jacoby

By: Bryant Furlow From: cancernetwork.com Updates to the National Comprehensive Cancer Network (NCCN) Guidelines® on breast cancer reflect maturing evidence bases and expanding treatment options, including a recently approved immunotherapy regimen for some patients with locally advanced or metastatic disease, according to speakers at the 2019 NCCN Annual Conference, held March 21–23 in Orlando, Florida. “There are many new and emerging options for …

View Post

New Patient Resource from NCCN Clears up Confusion around Highly Common Type of Skin Cancer

In In The News by Barbara Jacoby

New NCCN Guidelines for Patients: Squamous Cell Skin Cancer explains risk factors and treatment options for cancer type that impacts millions every year. The National Comprehensive Cancer Network® (NCCN®) has published a new book of patient information that explains prevention, diagnosis and treatment for squamous cell skin cancer—the second-most common skin cancer (after basal cell cancer). Squamous cell and basal …

View Post

Researchers Suggest Current Methods for Reporting Toxicities in Cancer Clinical Trials are Falling Short

In Clinical Studies News by Barbara Jacoby

Findings published in JNCCN examine the differences between patient- and clinician-reported outcomes; recommend a greater focus on the cumulative effect of multiple low-level toxicities. New research from Europe, published in the December 2018 issue of JNCCN—Journal of the National Comprehensive Cancer Network, finds that quality-of-life for people with cancer is reduced by an accumulation of low-level toxicities just as much …